Mechanisms of cardiac muscle insensitivity to a novel acetylcholinesterase inhibitor C-547

Journal of Cardiovascular Pharmacology

Volumn 53, Issue 2, 2009, Pages 162-166

  Abramochkin, Denis V ^a,b   Petrov, Konstantin A ^c   Zobov, Vladimir V ^c   Yagodina, Lilia O ^d   Nikolsky, Eugen E ^d   Rosenshtraukh, Leonid V ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c A E ARBUZOV INSTITUTE OF ORGANIC AND PHYSICAL CHEMISTRY   (Russian Federation)

^d KAZAN INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Russian Federation)

Author keywords

Acetylcholinesterase; Action potential; Atrium; Heart; Inhibitor

Indexed keywords

1,3 BIS[5 (DIETHYL O NITROBENZYLAMINO)PENTYL] 6 METHYLURACIL; ACETYLCHOLINE; ARMIN; ATROPINE; C 547; CHOLINESTERASE INHIBITOR; NEOSTIGMINE; UNCLASSIFIED DRUG; C 547 CPD; C-547 CPD; DRUG DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE; URACIL;

ACTION POTENTIAL; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EXTENSOR DIGITORUM LONGUS MUSCLE; MALE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RAT; SINUS RHYTHM; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROPHYSIOLOGY; HEART; HEART ATRIUM FUNCTION; IN VITRO STUDY; PHYSIOLOGY; SINUS NODE;

ACTION POTENTIALS; ANIMALS; ARMIN; ATRIAL FUNCTION; ATROPINE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HEART; NEOSTIGMINE; QUATERNARY AMMONIUM COMPOUNDS; RATS; SINOATRIAL NODE; URACIL;

EID: 65549139617     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31819867d1     Document Type: Article

References (13)

1. Anikienko KA, Bychikhin EA, Kurochkin VK, et al. Tetraalkylammonium derivatives of 6-methyluracil, a new class of cholinesterase inhibitors: characteristics of interaction with cholinesterases from different groups of animals. Dokl Biochem Biophys. 2001;376:39-43.
2. Zobov VV, Reznik VS, Aslyamova AA, et al. Charakteristika toxichnosty i bezopasnosty nekotorih a,v-bis(ammonio)alkanov, soderjaschih heterocyclicheskie i aromaticheskie radikaly. Toxicologichesky vestnik. 2004;4: 18-22.
3. Zobov VV, Petrov KA, Asliamova AA, et al. Selective blockade of locomotor muscles by uracil-containing tetraalkylammonium acetylcholinesterase inhibitors. Dokl Biol Sci. 2005;401:77-80.
4. Rosenshtraukh L, Danilo P Jr, Anyukhovsky EP, et al. Mechanisms for vagal modulation of ventricular repolarization and of coronary occlusioninduced lethal arrhythmias in cats. Circ Res. 1994;74:722-732. (Pubitemid 24297643)
5. Ellman GL, Courtney KD, Andres U Jr, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.
6. Abramochkin DV, Nikolsky EE, Rosenshtraukh LV. Effect of inhibitors of acetylcholinesterase on the parameters of the electric activity of rat atrial myocardium. Dokl Biol Sci. 2008;420:1-4.
7. Danilov AF, Ivanov IuIa. The mechanism of blockade and recovery of neuromuscular transmission under the influence of armin in experiments on cats. Farmakol Toksikol. 1972;35:571-575.
8. Petrov KA, Kovyazina IV, Zobov VV, et al. Different sensitivity of miniature endplate currents of the rat extensor digitorum longus, soleus and diaphragm muscles to a novel acetylcholinesterase inhibitor C-547. Physiol Res. 2006;55:585-589.
9. Silver AA. Histochemical investigation of cholinesterases at neuromuscular junctions in mammalian and avian muscle. J Physiol. 1963;169: 386-393.
10. Girard E, Bernard V, Minic J, et al. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice. Life Sci. 2007;80:2380-2385. (Pubitemid 46830784)
11. Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J. 1989;260:625-634.
12. Volpe LS, Biagioni TM, Marquis JK. In vitro modulation of bovine caudate muscarinic receptor number by organophosphates and carbamates. Toxicol Appl Pharmacol. 1985;78:226-234.
13. Katz LS, Marquis JK. Modulation of central muscarinic receptor binding in vivo by organophosphate paraoxon. Toxicol Appl Pharmacol. 1989; 101:114-123.